Purple Biotech Ltd (PPBT)
NASDAQ: PPBT · Real-Time Price · USD
3.990
-0.150 (-3.62%)
At close: Mar 26, 2026, 4:00 PM EDT
4.000
+0.010 (0.25%)
Pre-market: Mar 27, 2026, 4:23 AM EDT
Purple Biotech Market Cap
Purple Biotech has a market cap or net worth of $3.71 million as of March 26, 2026. Its market cap has decreased by -55.08% in one year.
Market Cap
3.71M
Enterprise Value
-5.62M
1-Year Change
-55.08%
Ranking
Category
Stock Price
$3.99
Market Cap Chart
Since July 14, 2013, Purple Biotech's market cap has decreased from $4.97M to $3.71M, a decrease of -25.39%. That is a compound annual growth rate of -2.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 26, 2026 | 5.94M | -15.10% |
| Dec 31, 2025 | 7.00M | -36.83% |
| Dec 31, 2024 | 11.07M | -48.88% |
| Dec 31, 2023 | 21.67M | -19.15% |
| Dec 29, 2022 | 26.80M | -60.87% |
| Dec 30, 2021 | 68.47M | 2.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genprex | 4.36M |
| Can-Fite BioPharma | 4.31M |
| Aptevo Therapeutics | 4.22M |
| Revelation Biosciences | 4.20M |
| Biodexa Pharmaceuticals | 4.09M |
| Indaptus Therapeutics | 3.99M |
| Azitra | 3.82M |
| Matinas BioPharma Holdings | 3.82M |